DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Navari RM, Rapoport BL, Powers D, Arora S, Clark-Snow R.
Rolapitant for the prevention of nausea in patients receiving highly or moderately emetogenic chemotherapy.
Cancer Med 2018;
7: 2943-2950
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.